Teladoc Health, Inc. (TDOC)
USD 9.46
(-6.06%)
USD 9.46
(-6.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.06 Billion USD | 1.41% |
| 2022 | 2.03 Billion USD | 20.65% |
| 2021 | 1.68 Billion USD | -9.76% |
| 2020 | 1.87 Billion USD | 217.84% |
| 2019 | 588.8 Million USD | 14.16% |
| 2018 | 515.75 Million USD | 94.27% |
| 2017 | 265.48 Million USD | 264.68% |
| 2016 | 72.8 Million USD | 42.26% |
| 2015 | 51.17 Million USD | 31.97% |
| 2014 | 38.77 Million USD | 365.44% |
| 2013 | 8.33 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.03 Billion USD | -1.67% |
| 2024 Q2 | 2.02 Billion USD | -0.51% |
| 2024 Q3 | 2.02 Billion USD | -0.03% |
| 2023 Q3 | 2.03 Billion USD | 0.63% |
| 2023 FY | 2.06 Billion USD | 1.41% |
| 2023 Q2 | 2.02 Billion USD | 0.17% |
| 2023 Q1 | 2.01 Billion USD | -0.97% |
| 2023 Q4 | 2.06 Billion USD | 1.59% |
| 2022 Q4 | 2.03 Billion USD | -0.67% |
| 2022 Q2 | 2.01 Billion USD | 3.51% |
| 2022 Q1 | 1.94 Billion USD | 15.45% |
| 2022 Q3 | 2.05 Billion USD | 1.64% |
| 2022 FY | 2.03 Billion USD | 20.65% |
| 2021 Q4 | 1.68 Billion USD | 1.43% |
| 2021 Q2 | 1.61 Billion USD | -8.15% |
| 2021 Q1 | 1.75 Billion USD | -6.34% |
| 2021 Q3 | 1.66 Billion USD | 3.41% |
| 2021 FY | 1.68 Billion USD | -9.76% |
| 2020 FY | 1.87 Billion USD | 217.84% |
| 2020 Q3 | 1.21 Billion USD | 8.4% |
| 2020 Q4 | 1.87 Billion USD | 53.61% |
| 2020 Q2 | 1.12 Billion USD | 86.42% |
| 2020 Q1 | 602.9 Million USD | 2.39% |
| 2019 Q3 | 574.69 Million USD | 2.13% |
| 2019 FY | 588.8 Million USD | 14.16% |
| 2019 Q4 | 588.8 Million USD | 2.46% |
| 2019 Q2 | 562.7 Million USD | 2.3% |
| 2019 Q1 | 550.06 Million USD | 6.65% |
| 2018 Q1 | 266.65 Million USD | 0.44% |
| 2018 FY | 515.75 Million USD | 94.27% |
| 2018 Q2 | 500.52 Million USD | 87.71% |
| 2018 Q3 | 507.41 Million USD | 1.38% |
| 2018 Q4 | 515.75 Million USD | 1.64% |
| 2017 Q4 | 265.48 Million USD | -38.85% |
| 2017 Q3 | 434.14 Million USD | 58.0% |
| 2017 FY | 265.48 Million USD | 264.68% |
| 2017 Q1 | 70.52 Million USD | -3.13% |
| 2017 Q2 | 274.77 Million USD | 289.63% |
| 2016 Q3 | 70.96 Million USD | 36.66% |
| 2016 Q4 | 72.8 Million USD | 2.58% |
| 2016 Q2 | 51.93 Million USD | 7.34% |
| 2016 Q1 | 48.38 Million USD | -5.46% |
| 2016 FY | 72.8 Million USD | 42.26% |
| 2015 Q2 | 65.06 Million USD | 41.46% |
| 2015 FY | 51.17 Million USD | 31.97% |
| 2015 Q4 | 51.17 Million USD | 0.85% |
| 2015 Q3 | 50.74 Million USD | -22.01% |
| 2015 Q1 | 45.99 Million USD | 18.61% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 38.77 Million USD | 0.0% |
| 2014 FY | 38.77 Million USD | 365.44% |
| 2013 FY | 8.33 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Well Corporation | 109.51 Million USD | -1786.701% |
| Doximity, Inc. | 177.97 Million USD | -1060.99% |
| Evolent Health, Inc. | 1.61 Billion USD | -28.134% |
| MultiPlan Corporation | 5.39 Billion USD | 61.71% |
| Phreesia, Inc. | 119.63 Million USD | -1627.152% |
| Veeva Systems Inc. | 1.26 Billion USD | -63.202% |